Zang, et al. Supplemental Figure 2

Aug 21, 2014

10 likes | 102 Views

Zang, et al. Supplemental Figure 2. Non-diabetic Diabetic Diabetic+S17834.

Share Presentation

Embed Code

Link

et al
diabetic mice
s17834
liver lipid
red o
representative oil

kirra

Download Presentation

Zang, et al. Supplemental Figure 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Zang, et al. Supplemental Figure 2 Non-diabetic Diabetic Diabetic+S17834 Supplemental Fig. 2. Treatment with S17834 prevents liver lipid accumulation in streptozotocin (STZ)-induced diabetic LDLR -/- mice. A representative Oil Red O staining of the livers in S17834-treated and untreated LDLR-/- diabetic mice.

Lim et al, Supplemental Figure S1.

Lim et al, Supplemental Figure S1. . a/b. a. a. b/c. a/b. c/d. c/d. c/d. d. e. Arsenic. Plant height (Cm). f. g. [mg/Kg]. 1.5. 5.0. 7.0. 0. 10. 50. 100. 150. 0. 200. 300. 400. 500. 0. As[ μ M]. Cadmium. a/b. a. b. b. c. c. d. d. d/e. e. f. g.

161 views • 5 slides

Patel et al Supplemental Figure S4

A . Patel et al Supplemental Figure S4. 4.1 ± 1.9. SK-ES-1. 13.0 ± 3.8. SK- N-MC. 0. 4. 12. RASSF1A Fold Induction with 5-AZA treatment. B . 39.5 ± 14.5. SK-ES-1. 185.5 ± 45.6. SK- N-MC. 24.3 ± 5.9. A673. 0. 100. 150. 200. 50. CALCA Fold Induction with 5-AZA treatment.

103 views • 1 slides

Supplemental Figure 3. Kiem et al.

1500. 600. 300. 200. 100. 1500. 600. 300. 200. 100. Supplemental Figure 3. Kiem et al. a. Copy Number in Foamy Transduced Lymphocytes. 3. 2. Copy Number. 1. 0. FV-SMPGW. FV-UsI-SMPGW. FV-HsI-SMPGW. FV-SC46-IMPGW. FV-UsI-SC46-IMPGW. FV-UsIIUsIUR5-SMPGW. FV-HsIIHsIHR5-SMPGW.

86 views • 1 slides

Yoon et al. Supplemental Figure S1

Yoon et al. Supplemental Figure S1. A. B. AGS. MKN-45. N87. CFPAC-1. PANC-1. AGS. MKN-45. N87. CFPAC-1. PANC-1. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Monolayer. Spheroid. Spheroid. Spheroid. Spheroid.

120 views • 1 slides

Supplemental Figure Fung et al.

Supplemental Figure Fung et al. A. B. Fluorescence and phase-contrast microscopic images showing ( A ) co-culture of MS5-GFP cells with human primary macrophages (including those encircled red). Note stellate network of MS5 cells (white arrows) spanning across an

143 views • 1 slides

Lim et al, Supplemental Figure S1.

Lim et al, Supplemental Figure S1. OsRING-H2 type : 4 OsRING-HC type : 6 OsRING-v type : 2. OsRING-H2 type : 5 OsRING-HC type : 1 OsRING-v type : 1. OsRING-H2 type : 9 OsRING-HC type : 8 OsRING-v type : 2. OsRING-H2 type : 9 OsRING-HC type : 8 OsRING-v type : 2.

214 views • 14 slides

Yoon et al. Supplemental Figure S3

Yoon et al. Supplemental Figure S3. A. AGS MKN-45 N87. Vismodegib. B. 5-fluoruracil. DMSO. Vismodegib. 5-fluoruracil. Cisplatin. Cisplatin. AGS Spheroid. MKN-45 Spheroid. N87 Spheroid.

139 views • 1 slides

Weaver et al. supplemental Figure 1

Weaver et al. supplemental Figure 1. A BALB/c. Epitope. Immunogen. Peptide. B1. B2. B3. B4. B5. B6. B7. B8. B9. B10. B11. B12. UG37(A). KVTFEPIPIHYCAPA (53). STVQCTHGIRPVVST (62). RIKQIINMWQRVGQA (104). GIVQQQSNLLRAIEAQQHLLKLTVWGIKQLQ (136,137,138,140).

108 views • 3 slides

Bush, et al., Supplemental Figure S5.

Bush, et al., Supplemental Figure S5. A. B. RNA Levels per Cell. C. D. E.

93 views • 1 slides

Geng et al. Supplemental Figure 1

Geng et al. Supplemental Figure 1. murine 3B11 tumor vascular endothelial cells. Human micro-vascular endothelial cells. Analog II. DMSO. Geng et al Supplemental Figure 2. Geng et al Supplemental Figure 3. Geng et al Supplemental Figure 4. Geng et al Supplemental Figure 5.

208 views • 6 slides

Tsutsumi et al., Supplemental Figure 1

80. 40. 80. 60. 0. 40. 10 0. 10 1. 10 2. 10 3. 20. Negative control. GA-FITC. GA-FITC + DMAG-N-oxide. 0. 10 0. 10 1. 10 2. 10 3. Negative control. mock. DMAG-N-oxide. Tsutsumi et al., Supplemental Figure 1. a. Cell Number (%). Fluorescence Intensity (log). b.

73 views • 1 slides

Bush, et al., Supplemental Figure S3.

Bush, et al., Supplemental Figure S3. B. A. C. WT 1. WT1 -- Normal Karyotype. DAPI. KO2 Endoreduplication. Mean = 1.4%. p value = 0.001. KO1 -- 39, XX, -4, chtb(1), chtb(11), chtb(12). KO 2. DAPI. Mean = 4.4%. E. D.

100 views • 1 slides

Supplemental Figure 1 Narainsamy et al.

Supplemental Figure 1 Narainsamy et al. A. B. Supplemental Figure 2 Narainsamy et al. A. B. 3276. 1375. 757. 1438. Supplemental Figure 3 Narainsamy et al. B. Positive ion mode. Negative ion mode. <10. 10-25. 25-35. 35-50. >50. <10. 10-25. 25-35. 35-50. >50. CV (%).

154 views • 7 slides

Supplemental Figure 1 Purandare et al.

Supplemental Figure 1 Purandare et al. A. B. JAK2. 0 Percent Control Cut-Off. 33 Percent Control Cut-Off.

74 views • 1 slides

Vernin et al., supplemental Figure 5

PI positive cells (%). Vernin et al., supplemental Figure 5.

104 views • 1 slides

Supplemental Figure 1, Ghielmetti et al

Supplemental Figure 1, Ghielmetti et al.

96 views • 1 slides

Supplemental Figure 3, Ghielmetti et al

medium. TB40/E. TB40/E-UV. Supplemental Figure 3, Ghielmetti et al.

109 views • 1 slides

Supplemental Figure 1 Geffroy et al.

CNL-B19. CNL-BA8. l B35. CNL-BA11. l B29. CNL-J11. l J9. Supplemental Figure 1 Geffroy et al. BAT93. JaloEEP558. Genetic position 1. Genetic position 1. 10Kb. CNL-J8. l J39. CNL-JA78. l J107. CNL-J9. l J15. Genetic position 2. CNL-B16. CNL-B17. l B10. Genetic position 3.

109 views • 1 slides

Kiem et al., Supplemental Figure 1

Kiem et al., Supplemental Figure 1. Relative luciferase expression. control. human CCR5-741. human CCR5-1024. macaque CCR5-741. macaque CCR5-1024.

93 views • 1 slides

Glazov et al., Supplemental Figure 6

Glazov et al., Supplemental Figure 6.

126 views • 1 slides

Frietze et al. Supplemental Figure 1

Frietze et al. Supplemental Figure 1.

66 views • 1 slides

Kuwano et al., Supplemental Figure S1

A. 5’UTR. CR. 3’UTR. MKP-1. 1. 249. 2015. 1352. CR. 3’UTR. 5’UTR. MKP-1. GAPDH. B. 5’UTR CR 3’UTR 3’UTR. RNA :. H 2 O 2 (h) : 0 1 2 0 1 2 0 1 2 0 1 2. HuR NF90.

149 views • 6 slides

More Related